Dr. Wade Aubry, M.D

NPI: 1447265814
Total Payments
$104,039
2023 Payments
$2,750
Companies
21
Transactions
68
Medicare Patients
345
Medicare Billing
$42,191

Payment Breakdown by Category

Consulting$95,093 (91.4%)
Other$4,384 (4.2%)
Travel$3,814 (3.7%)
Food & Beverage$747.79 (0.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $95,093 33 91.4%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,184 3 4.0%
Travel and Lodging $3,814 14 3.7%
Food and Beverage $747.79 17 0.7%
Grant $200.00 1 0.2%

Top Paying Companies

Company Total Records Latest Year
Greenwich Biosciences, Inc. $37,750 14 $0 (2021)
EMD Serono, Inc. $13,166 11 $0 (2019)
Intersect ENT, Inc. $7,600 1 $0 (2017)
VERTEX PHARMACEUTICALS INCORPORATED $6,810 10 $0 (2019)
EKOS Corporation $4,950 1 $0 (2018)
PneumRx, Inc $4,800 1 $0 (2018)
Novartis Pharmaceuticals Corporation $4,558 5 $0 (2019)
Pear Therapeutics (US), Inc. $4,200 1 $0 (2022)
Otonomy, Inc. $3,460 5 $0 (2017)
ABBVIE INC. $3,286 3 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2023 $2,750 1 Ferring Pharmaceuticals Inc. ($2,750)
2022 $9,986 5 Pear Therapeutics (US), Inc. ($4,200)
2021 $11,500 6 Greenwich Biosciences, Inc. ($11,500)
2020 $28,050 9 Greenwich Biosciences, Inc. ($26,250)
2019 $26,759 22 EMD Serono, Inc. ($12,365)
2018 $10,551 8 EKOS Corporation ($4,950)
2017 $14,443 17 Intersect ENT, Inc. ($7,600)

All Payment Transactions

68 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
08/10/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Consulting Fee Cash or cash equivalent $2,750.00 General
Category: GASTROENTEROLOGY
09/09/2022 JAZZ PHARMACEUTICALS INC. Consulting Fee Cash or cash equivalent $2,500.00 General
04/15/2022 ABBVIE INC. Consulting Fee Cash or cash equivalent $3,150.00 General
04/15/2022 AbbVie Inc. Travel and Lodging Cash or cash equivalent $80.48 General
04/15/2022 ABBVIE INC. Travel and Lodging In-kind items and services $55.98 General
03/17/2022 Pear Therapeutics (US), Inc. Consulting Fee Cash or cash equivalent $4,200.00 General
08/31/2021 Greenwich Biosciences, Inc. Consulting Fee Cash or cash equivalent $750.00 General
07/06/2021 Greenwich Biosciences, Inc. Consulting Fee Cash or cash equivalent $1,000.00 General
05/21/2021 Greenwich Biosciences, Inc. Consulting Fee Cash or cash equivalent $1,500.00 General
04/19/2021 Greenwich Biosciences, Inc. Consulting Fee Cash or cash equivalent $750.00 General
03/08/2021 Greenwich Biosciences, Inc. Consulting Fee Cash or cash equivalent $3,500.00 General
01/12/2021 Greenwich Biosciences, Inc. Consulting Fee Cash or cash equivalent $4,000.00 General
12/15/2020 Greenwich Biosciences, Inc. Epidiolex (Drug) Consulting Fee Cash or cash equivalent $5,500.00 General
Category: Neurology
11/24/2020 Greenwich Biosciences, Inc. Epidiolex (Drug) Consulting Fee Cash or cash equivalent $5,000.00 General
Category: Neurology
10/19/2020 Greenwich Biosciences, Inc. Epidiolex (Drug) Consulting Fee Cash or cash equivalent $4,000.00 General
Category: Neurology
09/21/2020 Greenwich Biosciences, Inc. Epidiolex (Drug) Consulting Fee Cash or cash equivalent $2,000.00 General
Category: Neurology
08/24/2020 Greenwich Biosciences, Inc. Epidiolex (Drug) Consulting Fee Cash or cash equivalent $1,500.00 General
Category: Neurology
07/21/2020 Greenwich Biosciences, Inc. Epidiolex (Drug) Consulting Fee Cash or cash equivalent $2,750.00 General
Category: Neurology
06/22/2020 Greenwich Biosciences, Inc. Epidiolex (Drug) Consulting Fee Cash or cash equivalent $1,500.00 General
Category: Neurology
05/22/2020 Greenwich Biosciences, Inc. Epidiolex (Drug) Consulting Fee Cash or cash equivalent $4,000.00 General
Category: Neurology
05/06/2020 Endogastric Solutions, Inc ESOPHYX (Device) Consulting Fee Cash or cash equivalent $1,800.00 General
Category: GERD
07/16/2019 Allergan Inc. Consulting Fee Cash or cash equivalent $3,015.00 General
07/16/2019 Allergan Inc. Food and Beverage In-kind items and services $10.59 General
06/12/2019 VERTEX PHARMACEUTICALS INCORPORATED Travel and Lodging In-kind items and services $32.00 General
06/12/2019 VERTEX PHARMACEUTICALS INCORPORATED Travel and Lodging In-kind items and services $30.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 90 184 $29,691 $10,926
2022 4 118 221 $40,218 $14,853
2021 2 69 138 $25,842 $9,858
2020 3 68 99 $8,834 $6,554
Total Patients
345
Total Services
642
Medicare Billing
$42,191
Procedure Codes
15

All Medicare Procedures & Services

15 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Facility 2023 29 58 $9,802 $3,368 34.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 16 25 $7,225 $2,909 40.3%
99307 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes Facility 2023 28 73 $7,008 $2,432 34.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 17 28 $5,656 $2,218 39.2%
99308 Follow-up nursing facility visit per day, typically 15 minutes Facility 2022 36 74 $12,506 $4,568 36.5%
99308 Follow-up nursing facility visit per day, typically 15 minutes Office 2022 33 81 $13,689 $4,425 32.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 20 25 $7,225 $3,011 41.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 17 27 $5,454 $2,303 42.2%
99307 Follow-up nursing facility visit per day, typically 10 minutes Facility 2022 12 14 $1,344 $546.70 40.7%
99308 Subsequent nursing facility visit, typically 15 minutes per day Facility 2021 39 98 $16,562 $6,085 36.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 13 21 $6,069 $2,574 42.4%
99308 Subsequent nursing facility visit, typically 15 minutes per day Office 2021 17 19 $3,211 $1,199 37.3%
99308 Subsequent nursing facility visit, typically 15 minutes per day Facility 2020 36 67 $5,432 $4,180 77.0%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 18 18 $3,110 $2,191 70.5%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2020 14 14 $291.91 $183.15 62.7%

About Dr. Wade Aubry, M.D

Dr. Wade Aubry, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447265814.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wade Aubry, M.D has received a total of $104,039 in payments from pharmaceutical and medical device companies, with $2,750 received in 2023. These payments were reported across 68 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($95,093).

As a Medicare-enrolled provider, Aubry has provided services to 345 Medicare beneficiaries, totaling 642 services with total Medicare billing of $42,191. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.

Practice Information

  • Specialty Endocrinology, Diabetes & Metabolism
  • Other Specialties Diabetes & Metabolism
  • Location San Francisco, CA
  • Active Since 07/31/2006
  • Last Updated 01/14/2008
  • Taxonomy Code 207RE0101X
  • Entity Type Individual
  • NPI Number 1447265814

Products in Payments

  • Epidiolex (Drug) $26,250
  • Bavencio (Biological) $12,831
  • EKOSONIC (Device) $4,950
  • PNEUMRX COILS (Device) $4,800
  • BEOVU (Drug) $3,990
  • OTIPRIO (Drug) $3,460
  • REBYOTA (Biological) $2,750
  • ESOPHYX (Device) $1,800
  • Nucleus (Device) $700.00
  • Spiration Valve System (Device) $700.00
  • AFINITOR (Drug) $568.00
  • GENERAL - STENTS (Device) $200.00
  • i-FACTOR Putty (Device) $17.50

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Endocrinology, Diabetes & Metabolism Doctors in San Francisco